Charles Schwab Investment Management Inc. Has $9.53 Million Position in Unilever PLC (NYSE:UL)

Charles Schwab Investment Management Inc. boosted its holdings in Unilever PLC (NYSE:UL) by 11.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 168,093 shares of the company’s stock after buying an additional 17,066 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Unilever were worth $9,531,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the business. Timber Creek Capital Management LLC increased its position in Unilever by 0.5% in the 3rd quarter. Timber Creek Capital Management LLC now owns 39,530 shares of the company’s stock worth $2,568,000 after buying an additional 182 shares during the period. Farmers & Merchants Investments Inc. increased its position in Unilever by 3.4% in the 4th quarter. Farmers & Merchants Investments Inc. now owns 5,646 shares of the company’s stock worth $320,000 after buying an additional 185 shares during the period. Alhambra Investment Management LLC increased its position in Unilever by 4.2% in the 4th quarter. Alhambra Investment Management LLC now owns 4,586 shares of the company’s stock worth $260,000 after buying an additional 186 shares during the period. Phillips Wealth Planners LLC increased its position in Unilever by 2.2% in the 4th quarter. Phillips Wealth Planners LLC now owns 8,970 shares of the company’s stock worth $495,000 after buying an additional 193 shares during the period. Finally, Three Bridge Wealth Advisors LLC increased its position in Unilever by 0.6% in the 4th quarter. Three Bridge Wealth Advisors LLC now owns 34,740 shares of the company’s stock worth $1,970,000 after buying an additional 198 shares during the period. 9.67% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on UL. DZ Bank raised Unilever from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Sanford C. Bernstein upgraded Unilever from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 9th. StockNews.com upgraded Unilever from a “hold” rating to a “buy” rating in a research report on Friday, March 7th. Finally, Royal Bank of Canada cut Unilever from a “sector perform” rating to an “underperform” rating in a research report on Monday, January 6th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $66.33.

Unilever Trading Down 1.0 %

UL opened at $58.64 on Friday. The stock’s 50 day simple moving average is $57.28 and its 200-day simple moving average is $59.49. Unilever PLC has a 1 year low of $46.46 and a 1 year high of $65.87. The stock has a market cap of $145.50 billion, a PE ratio of 16.80, a P/E/G ratio of 1.60 and a beta of 0.47.

Unilever Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Friday, February 28th will be given a $0.4674 dividend. This represents a $1.87 dividend on an annualized basis and a yield of 3.19%. The ex-dividend date of this dividend is Friday, February 28th. Unilever’s dividend payout ratio (DPR) is 53.01%.

About Unilever

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.